Cabka H1 Loss Widens; Sales Down 2%

Cabka N.V. (CABKA.AS) reported a widened net loss of €4.7 million in H1 2025, primarily driven by a deliberate €5.6 million inventory reduction that pressured short-term profitability and contributed to a 2% sales decline to €90 million. While operational EBITDA fell to €9.1 million, this strategic inventory reduction, part of the 'Shift program' prioritizing cash flow and cost efficiency, significantly improved the company's net debt position and reduced net working capital by 26%, concurrently improving gross operating margin by over 200 basis points to 51.7%.

Analysis

Cabka N.V. reported a significant widening of its net loss to €4.7 million in H1 2025, driven almost entirely by a deliberate €5.6 million inventory reduction. This strategic move, part of the company's "Shift program," prioritized long-term balance sheet health over short-term earnings, successfully reducing net working capital by 26% to €28.6 million and improving the company's net debt position. While this inventory adjustment pressured operational EBITDA, which fell to €9.1 million, underlying profitability metrics showed strength, with the gross operating margin improving by over 200 basis points to 51.7%. The top line saw a modest 2% sales decline to €90 million, reflecting a divergence in regional performance; a refreshed commercial strategy fueled a 9% sales increase in the U.S., which was offset by weaker performance in Europe. The results illustrate a company in a strategic transition, sacrificing immediate profitability for enhanced operational efficiency and cash flow.

Key Decisions for Investors

• Investors should look past the headline net loss, as it is primarily the result of a deliberate, one-off strategic inventory reduction designed to strengthen the balance sheet.
• The 9% sales growth in the U.S. and the 200-basis-point improvement in gross operating margin are key positive indicators that the 'Shift program' is yielding operational benefits.
• Future performance will hinge on the company's ability to stabilize its European sales while maintaining the positive momentum in the U.S. and preserving margin gains once the inventory adjustment is complete.